We are live on ! Find out more
ABMD

Abiomed Inc

Delisted

ABMD was delisted on the 21st of December, 2022.

527 hedge funds and large institutions have $16B invested in Abiomed Inc in 2018 Q2 according to their latest regulatory filings, with 153 funds opening new positions, 157 increasing their positions, 171 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

428% more first-time investments, than exits

New positions opened: 153 | Existing positions closed: 29

40% more funds holding in top 10

Funds holding in top 10: 1521 (+6)

40% more capital invested

Capital invested by funds: $11.5B → $16B (+$4.55B)

30% more funds holding

Funds holding: 405527 (+122)

8% less repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 171

21% less call options, than puts

Call options by funds: $167M | Put options by funds: $212M

Holders
527
Holders Change
+122
Holders Change %
+30.12%
% of All Funds
12.07%
Holding in Top 10
21
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+40%
% of All Funds
0.48%
New
153
Increased
157
Reduced
171
Closed
29
Calls
$167M
Puts
$212M
Net Calls
-$45.4M
Net Calls Change
-$39.3M
Name Holding Trade Value Shares
Change
Change in
Stake
RIM
451
Rampart Investment Management
Connecticut
$175K +$155K +427 New
ACS
452
Archford Capital Strategies
Illinois
$164K
SNT
453
Security National Trust
West Virginia
$164K
OMCS
454
Old Mutual Customised Solutions
South Africa
$164K +$145K +400 New
Walleye Trading
455
Walleye Trading
New York
$159K +$141K +388 New
JA
456
JOYN Advisors
Georgia
$155K +$42.7K +118 +45%
C
457
Cerebellum
California
$151K +$134K +369 New
WAM
458
Wealthspire Advisors (Maryland)
Maryland
$147K -$22.5K -62 -15%
ASN
459
Advisory Services Network
Georgia
$140K -$11.2K -31 -8%
Winslow Capital Management
460
Winslow Capital Management
Minnesota
$132K -$284M -784,769 -100%
BFEC
461
Benjamin F. Edwards & Company
Missouri
$127K +$39.9K +110 +55%
CCA
462
Catalyst Capital Advisors
New York
$123K +$109K +300 New
NEI
463
Northwest & Ethical Investments
Ontario, Canada
$123K -$36.2K -100 -25%
CLOS
464
Compagnie Lombard Odier SCmA
Switzerland
$115K +$72.5K +200 +250%
EA
465
Edge Advisors
Georgia
$106K
CCMW
466
Cypress Capital Management (Wyoming)
Wyoming
$90K +$61.6K +170 +340%
HNB
467
Huntington National Bank
Ohio
$82K -$27.2K -75 -27%
BSG
468
Black Swift Group
Colorado
$82K +$72.5K +200 New
GEA
469
Glen Eagle Advisors
New Jersey
$81.8K
HH
470
HWG Holdings
Texas
$80K +$70.6K +195 New
PHK
471
Point72 Hong Kong
Hong Kong
$56K +$49.3K +136 New
SFM
472
Signet Financial Management
New Jersey
$51K +$45.3K +125 New
MIFH
473
Migdal Insurance & Financial Holdings
Israel
$50K +$44.6K +123 New
QCG
474
Quadrant Capital Group
Ohio
$49K
GLI
475
Guardian Life Insurance
New York
$47K +$42K +116 New

ABMD Hedge Fund Activity: Q2 2018 in Review

527 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2018, worth a combined $16B — up 40% from $11.5B a quarter earlier.

Buyers outnumbered sellers: 153 funds opened new ABMD positions and 29 closed out — a net gain of 124 holders — while 157 added to existing stakes and 171 trimmed.

The largest buyer was Vanguard Group, adding an estimated $297M. The largest seller was BlackRock, cutting an estimated $315M.

  • 527 institutional investors held Abiomed Inc (ABMD) as of Q2 2018, up from 405 in Q1 2018.
  • Funds reported $16B of Abiomed Inc stock for Q2 2018, up 40% quarter-over-quarter.
  • 153 funds opened new Abiomed Inc positions in Q2 2018 and 29 closed out, a net change of +124 holders.
  • The largest Abiomed Inc buyer in Q2 2018 was Vanguard Group, an estimated $297M added.
  • The largest Abiomed Inc seller in Q2 2018 was BlackRock, an estimated $315M sold.

Based on aggregated 13F filings for Q2 2018.